3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
1
Prolactinoma
1
Pituitary ACTH Hypersecretion
1
Paraproteinemias
1
Multiple Myeloma
1
Monoclonal Gammopathy of Undetermined Significance
1
Mesothelioma, Malignant
1
Immunoglobulin Light-chain Amyloidosis
1
Head and Neck Neoplasms
1
Gigantism
1
Congenital Abnormalities
1
Combined Pituitary Hormone Deficiency
1
Carcinogenesis
1
Acromegaly
1
Interventions
pembrolizumab
8
cemiplimab
5
Nivolumab
4
Ipilimumab
4
Blood Specimen Collection
3
lifileucel
2
avelumab
2
aldesleukin
2
Niacinamide
2
Cyclophosphamide
2
toripalimab
1
tislelizumab
1
oxycodone-acetaminophen
1
lenvatinib
1
fludarabine
1
epacadostat
1
encorafenib
1
durvalumab
1
dostarlimab
1
brodalumab
1
binimetinib
1
atezolizumab
1
Vitamin A
1
Surgical Procedures, Operative
1
Sunscreening Agents
1
Standard of Care
1
Specimen Handling
1
Resistance Training
1
Radiotherapy
1
Niacin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Skin Neoplasms
×
Tissue Banks
×
90 days
×
Clear all
No trials found.